Alternative Financing Approaches

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 036″] As venture investors shift to later stages, start-ups will have to look harder for new sources of innovation. A panel at OIS@ASCRS discusses how new sources of capital can sustain the creation of new companies.

Read More

Alternative Financing Approaches

Moderator: Tom Salemi Tom serves as Content Director for Healthegy, joining the company in 2014, to create and manage a new line of podcasts, publications and other editorial products. View Full Profile Panelists: William J. Link, PhD Bill was Founder, Chairman and CEO of Chiron Vision, sold in 1997. Bill founded and served as President…

Read More

Alphaeon’s Grant Explains Innovative New Model

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 034″] Alphaeon is tapping physicians for unprecedented involvement in finding and funding new treatments. Hear how the company sees the future of health care.

Read More

Ophthalmology By The Numbers With Jon Norris of SVB

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 026″] Jon Norris, Managing Director of Health Care at Silicon Valley Bank, gives a sneak peak on his coming report on the health care sector and discusses why ophthalmology continues to be a strong source of innovation. Podcast Guest Jonathan Norris Jon Norris is a Managing Director with SVB Healthcare team,…

Read More

Eleven’s Celniker Talks Leadership, Public Markets & Phase III Dry Eye Trials

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 021″] Eleven Biotherapeutics capitalized on exciting technology and promising clinical results for its lead dry eye product to stage a successful IPO in 2014. Abbie C. Celniker, PhD, President and CEO, talks frankly about her leadership style, dealing with public investors and how she’s managing high expectations for lead product EBI-005.…

Read More

How to Do M&A Well

Highlights of a discussion between the ophthalmology sector’s top execs about how to do M&A right. Moderator: Jim Mazzo Jim Mazzo is the Executive Chairman and CEO for AcuFocus. AcuFocus specializes in presbyopia correction and is known for its revolutionary KAMRA inlay which was recently FDA approved. View Full Profile Panelists: Jeff George Jeff was…

Read More

CEOs Share Lessons from IPOs

A panel of ophthalmology executives at the Ophthalmology Innovation Summit discuss the perks and pitfalls of going public. Moderator: David Guyer, MD Under Dr. Guyer’s leadership, Ophthotech raised more than $350 million in financing from May to September 2013, including a $192 million IPO, a multi-tranched $125 million royalty financing deal with Novo A/S and…

Read More

Private Funding Trends In Healthcare

Jon Norris, senior vice president of Silicon Valley Bank, delivers a comprehensive report on the state of private opthalmology financing. Presenter: Jonathan Norris Jon Norris is a Managing Director with SVB Healthcare team, responsible for new business development. View Full Profile

Read More

The Ophthalmology Market – A View Of The Public Sector & Exit Trends

Jeffrey Hoffman, Managing Director and Head of West Coast Healthcare Investment Banking for J.P. Morgan, told attendees at the Ophthalmology Innovation Summit in Chicago how ophthalmology companies are helping to drive up the biotechnology sector. Presenter: Jeff Hoffman Jeff Hoffman is a Senior Managing Director at Guggenheim Securities, LLC. He has more than 25 years…

Read More

Eye Companies Helping Health Care Stand Out

Healthcare stocks are outperforming the indices, and ophthalmic companies are helping to fuel a large part of that growth, Jeffrey Hoffman, Managing Director and Head of West Coast Healthcare Investment Banking for J.P. Morgan, told attendees at the Ophthalmology Innovation Summit in Chicago. “Healthcare has outperformed most other sectors, and it has been primarily driven…

Read More

How Thoughtful Consolidation Can Benefit Ophthalmology

OIS Podcast

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 014″] At the recent Ophthalmology Innovation Summit in Chicago, Jeff George, President & Global Head of Alcon; David E.I. Pyott, CEO of Allergan; Murthy V. Simhambhatla, PhD, President of Abbott Medical Optics; and

Read More

How Do You Talk to an Angel?

Ophthalmic Surgeon, Eric D. Kanter, MD, of Retina-Vitreous Consultants, balances his work at his busy New Jersey practice with his commitments as a principal member of Mid Atlantic Bio Angels. Members of MABA invest between $250,000 to $500,000 in life science start-ups of all types. Submissions for review have included ophthalmic drug, various types of…

Read More